Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |